Gut-regulated immune pathways

Gut-regulated immune pathways represent the ensemble of interactions between the gut microbiota, intestinal epithelium, and mucosal immune system. These pathways coordinate local and systemic immunity through actions such as metabolite signaling, antigen presentation, T/B cell differentiation, and cytokine production. Key components include gut-associated lymphoid tissue, pattern recognition receptors (like Toll-like receptors and NOD-like receptors), innate lymphoid cells (such as ILC3s), and microbial metabolites (e.g., short-chain fatty acids). These influence processes such as tolerance to commensals, prevention of pathogenic invasion, inflammation regulation, and maintenance of barrier integrity. Disruption or dysregulation contributes to inflammatory disease, autoimmunity, and susceptibility to infection[1][2][3][4][5]. This entry is conceptually important for immunology and microbiome research, but does not map to a standard drug target. For deeper structured information, one would need to specify molecules such as "Toll-like receptor 4", "Group 3 innate lymphoid cell", "GPR43", etc., all of which are part of the gut's immune regulatory network[1][2][3][5].

Other names

Gut microbiota-immune interactionGut-immune crosstalkMicrobiota-regulated immune signalingIntestinal immune pathways

General immunomodulation, Microbiome modulation, Cytokine signaling modulation, Barrier function enhancement